News

  1. Aegis Sciences Corporation expands InterACT Rx™ Testing Capabilities

    Nashville, Tennessee (May 6, 2020) – Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative medication compliance…

    Nashville, Tennessee (May 6, 2020) – Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative medication compliance testing and consulting services to providers, implemented an expanded InterACT Rx™ test offering on April 1, 2020.  Testing will now include over 180 total analytes, and more than 130 drugs or substances. In order to better serve healthcare providers,…

  2. Aegis Sciences Corporation Doubles Capacity for Coronavirus Disease 2019 (COVID-19) Testing

    Capacity for 7,000 tests a day begins May 4 in response to community need Nashville, Tennessee (April 27, 2020) – Aegis Sciences Corporation, a leading…

    Capacity for 7,000 tests a day begins May 4 in response to community need Nashville, Tennessee (April 27, 2020) – Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative medication compliance testing and consulting services to providers, announced expanded capacity to incrementally ramp up to 7,000 tests per day since first making COVID-19 testing available on…

  3. Aegis Sciences Corporation gears up for COVID-19 testing

     April 16, 2020 - Aegis Sciences was featured on WSMV News4 Nashville - view clip For more information and details about how you can access Aegis’s COVID-19…

     April 16, 2020 - Aegis Sciences was featured on WSMV News4 Nashville - view clip For more information and details about how you can access Aegis’s COVID-19 testing service, please visit www.aegislabs.com, email COVIDtest@aegislabs.com or call 615-99COVID (615.992.6843).  

  4. Aegis Sciences Corporation Launches Test for Coronavirus Disease 2019 (COVID-19)

    Capacity for 3,500 tests a day begins April 15; results available within 24 hours Nashville, Tennessee (April 13, 2020) – Aegis Sciences Corporation,…

    Capacity for 3,500 tests a day begins April 15; results available within 24 hours Nashville, Tennessee (April 13, 2020) – Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative medication compliance testing and consulting services to providers, will serve as a regional reference laboratory for COVID-19 testing being directed by Federal, State, and Local COVID-19…

  5. Aegis Sciences COVID-19 Update

    To Our Customers, Aegis Sciences would like to take a moment to say ‘Thank You’ to all of our partners and customers who continue to service their communities’…

    To Our Customers, Aegis Sciences would like to take a moment to say ‘Thank You’ to all of our partners and customers who continue to service their communities’ healthcare needs amidst the current challenges with Coronavirus (COVID-19.)  Our laboratory is and will remain fully operational and available to you as your practice continues providing essential health services in these extraordinary times. …

  6. Aegis Sciences Launches New Pharmacogenetic Testing

    Nashville, Tennessee (October 14, 2019) – Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative medication compliance…

    Nashville, Tennessee (October 14, 2019) – Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative medication compliance testing and consulting services to providers, has launched a new pharmacogenetic (PGx) test that allows for identification of specific gene variants that may impact how behavioral and pain management drugs affect patients. The test results provide…

  7. We are hiring! Laboratory Open House

    We are hiring! Laboratory Open House

    Aegis Sciences Corporation, a national leader in healthcare and laboratory sciences, is hiring! Thursday, September 5th, 20195:00 p.m. to 7:00 p.m.  501…

    Aegis Sciences Corporation, a national leader in healthcare and laboratory sciences, is hiring! Thursday, September 5th, 20195:00 p.m. to 7:00 p.m.  501 Great Circle Road (Metro Center) | Nashville, TN Parking behind building; use back entrance. Meet with our recruiters and laboratory leaders to learn about our exciting laboratory opportunities and competitive benefits package. We are seeking…

  8. Aegis now an Anthem Blue Cross and Blue Shield of Georgia participating provider

    NASHVILLE, TN (June 17, 2019) - Aegis Sciences Corporation is pleased to announce that effective June 17, 2019 we will be a participating laboratory provider…

    NASHVILLE, TN (June 17, 2019) - Aegis Sciences Corporation is pleased to announce that effective June 17, 2019 we will be a participating laboratory provider with Anthem Blue Cross and Blue Shield in Georgia for PPO, Medicare Advantage and Indemnity products. Our product participation with Anthem Blue Cross and Blue Shield in Georgia will allow referring physicians to utilize Aegis’ laboratory services…

  9. New Research Shows How Diagnostic Testing Can Advance the Identification and Treatment of Harmful Drug-Drug Interactions

    New Research Shows How Diagnostic Testing Can Advance the Identification and Treatment of Harmful Drug-Drug Interactions

    Findings of a recently published two-part study demonstrate that InterACT Rx™ can significantly enhance diagnosis and treatment of DDIs, improving patient…

    Findings of a recently published two-part study demonstrate that InterACT Rx™ can significantly enhance diagnosis and treatment of DDIs, improving patient outcomes NASHVILLE, TN (December 5, 2018) - Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative testing and consulting services to providers, conducted a two-part research study to measure the performance…

  10. New Research Reveals the Prevalence of Drug-Drug Interactions and the Economic Impact on the Healthcare System

    New Research Reveals the Prevalence of Drug-Drug Interactions and the Economic Impact on the Healthcare System

    Studies show an alarming prevalence of concurrent ingestion of interacting substances by patients and that providing physicians with clear, objective information…

    Studies show an alarming prevalence of concurrent ingestion of interacting substances by patients and that providing physicians with clear, objective information leads to a reduction of interactions and costs for patients NASHVILLE, TN (November 5, 2018) – Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative testing and consulting services to providers, recently…